Metabolic therapy with Sodium R lipoate plus hydroxycitrate: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 March 2024

21 March 2024

  • curprev 05:0505:05, 21 March 2024Lazy talk contribs 1,257 bytes +1,257 Created page with "{{TreatmentInfo |drug_name=Sodium R Lipoate and Hydroxycitrate (METABLOC) |FDA_approval=No (Used in investigational metabolic therapy for brain tumors) |used_for=Investigational use in brain tumor treatment, including primary and metastatic gliomas |clinical_trial_phase=Early clinical evaluation in a small case series |common_side_effects=Not specified in the provided information |OS_with=Varies; one GBM patient had a significant tumor shrinkage, others showed extended p..."